CAFs are the primary source of IL-6 in the tumor microenvironment of GC, and CAF-produced IL-6 activates the Jak1-STAT3 pathway in GC cells via paracrine signaling, resulting in the development of chemotherapeutic resistance. The gene discussed is STAT3; the disease is gastric cancer.